Company intelligence / Profile preview

Cerebro NeuroTech

Miami, Florida, United Statescerebroneurotech.com ↗

Ownership: Private
Employees: ~8
Development stage: Preclinical

Overview

Cerebro NeuroTech’s TRINITY platform uses AI, machine learning, spatial computing, and extended reality to rapidly detect traumatic brain injuries and sport-related concussions. The technology is currently in the research phase with ongoing beta testing; it has not yet received FDA clearance for commercial distribution. Early partnerships with healthcare systems are underway to validate its accuracy in real-world settings.

Therapeutic areas: Neurology
Modalities: DeviceSoftware as a Medical Device (SaMD)Artificial intelligence-based diagnostics
Industry: Digital Health Medical Devices

Partnerships

Community Health Center of BuffaloLakeshore Foundation collaboration for product enhancement with people with disabilitiesInnovation Depot/Birmingham tech ecosystem support

Beyond the preview

Go deeper on Cerebro NeuroTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerebro NeuroTech.

Explore the full profile